TSX News -
United Way of Metropolitan Dallas Chooses SylogistMission
CALGARY, Alberta, May 08, 2024 (GLOBE NEWSWIRE) — Sylogist (TSX: SYZ) (“Sylogist” or the “Company”), a leading public sector SaaS […]
Jewelry Franchisee The Michaels Group Chooses Clip for Secure, Cost-Effective Cash Management
BOSTON, May 08, 2024 (GLOBE NEWSWIRE) — Clip Money, Inc. (“Clip”) (TSXV:CLIP) (OTCQB:CLPMF), a leading provider of end-to-end cash management […]
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a […]
Puma Launches 2024 Exploration Program at Jonpol Gold
RIMOUSKI, Quebec, May 08, 2024 (GLOBE NEWSWIRE) — Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) is […]
Core Molding Technologies to Participate in the EF Hutton Annual Global Conference in NYC
COLUMBUS, Ohio, May 08, 2024 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the […]
Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) […]
Gen Z Consumers Are Using Credit More, and Differently, than Their Millennial Counterparts at the Beginning of their Credit Journeys
LAS VEGAS, May 08, 2024 (GLOBE NEWSWIRE) — Gen Z consumers are tapping into credit at higher levels than their […]
Terra Balcanica Announces Proposed Share Consolidation and Engages Market Maker
Vancouver, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) announces […]
Treatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” […]
Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel […]
